XP

X4 Pharmaceuticals

XFOR
NASDAQHealth Care

Income Statement

Total Revenue$2.56M
Gross Profit$1.76M
Operating Income$-36.4M
EBITDA$-25.99M
EBIT$-28.37M
Pre-tax Income$-79.16M
Net Income$-37.45M

Balance Sheet

Cash Equivalent$90.21M
Total Debt$73.2M
Book Value$44.31M
Book Value Per Share7.88

Key Ratios

Return on Equity (ROE)-169.08%
Return on Assets (ROA)-25.57%
Return on Invested Capital (ROI)-38.38%
Net Profit Margin-1464.61%
Current Ratio3.41
Quick Ratio3.16
Long-Term Debt / Equity3.41